It has been suggested that the behavior and function of Paneth cells in metaplasia are different from those found in normal intestinal mucosa. In this study, we investigated whether calnexin, a protein involved in secretory pathways, might be associated with differentiation and function of Paneth cells in normal small intestine, in complete intestinal metaplasia of the stomach, and in Paneth cell-rich adenomas. Differentiation and function of Paneth cells was monitored by Ki67, lysozyme, and morphologic features. Using a newly established monoclonal antibody, we found that calnexin is regularly synthesized by Paneth cells of normal small intestine. In these cells, the staining intensity of calnexin was inversely correlated with their content of secretory granules (lysozyme). In contrast, Paneth cells of intestinal metaplasia and Paneth cell-rich adenomas showed a reduced immunostaining of both calnexin and lysozyme. Moreover, these Paneth cells synthesized the proliferation marker Ki67, a phenomenon that was never observed in Paneth cells of normal small intestine. In vitro experiments using CaCo2 cells showed that the expression of calnexin is not directly affected by the induction of mitosis. In conclusion, calnexin probably reflects the status of Paneth cell differentiation and function. The results do not necessarily indicate that calnexin has a function in Paneth cell proliferation. (Lab Invest 2002, 82:1647-1659.
T
he four principal epithelial cell types of the human small intestinal mucosa (absorptive, goblet, Paneth, and endocrine cells) derive from a multipotent stem cell located near the base of crypts of Lieberkühn. In contrast to absorptive and goblet cells, which migrate in approximately 5 days from the crypt depths to the surface, endocrine cells and Paneth cells differentiate during a downward migration to the base of crypts. Paneth cells reside there for approximately 20 days (Bry et al, 1994) . Paneth cells are generally recognized in hematoxylin and eosinstained sections by their large eosinophilic apical secretory granules and their characteristic ultrastructural pattern (Otto, 1973) . Functions that have been attributed to Paneth cells include modulation of the intestinal microflora and maintenance of the mucosal defense barrier through production and secretion of several antimicrobial peptides, such as lysozyme, secretory phospholipase A 2 , and ␣-defensins (Nevalainen et al, 1998; Ouellette, 1999; Ouellette and Bevins, 2001 ). In addition, Paneth cells can also produce further regulatory molecules including growth factors, suggesting that Paneth cells may regulate the proliferation and differentiation programs of epithelial cell lineages by short-circuit paracrine loops (Bry et al, 1994; Ganz, 2000) .
In humans, Paneth cell metaplasia is preferentially found in atrophic gastritis (Wong et al, 2000) . Other nonmalignant pathologic conditions associated with Paneth cell metaplasia are diversion colitis, ulcerative colitis, and collagenous colitis (Goff et al, 1997; Shah et al, 1998; Stamp et al, 1992; Vujanic and Dojcinov, 2000; Weaver et al, 1992) . Although the metaplastic tissue of the stomach has some morphologic features in common with the small intestinal mucosa, a series of studies has provided evidence that cellular differentiation in metaplastic tissues is different from that found in normal intestinal mucosa (Cahill et al, 1996; Inada et al, 2001; Wong et al, 2000; Yabuki et al, 1997) . It is suggested that the normal growth control processes of Paneth cells are disturbed in complete intestinal metaplasia (Wong et al, 2000) . Thus, the presence of intestinal metaplasia of the stomach is thought to increase the risk for developing gastric cancer (Filipe et al, 1994; Stemmermann, 1994; Wong et al, 2000; You et al, 1993) . However, malignant transformation of intestinal Paneth cells into "Paneth cell-carcinoma" has not been established yet, but Paneth cells and/or Paneth-like cells are frequently found in malignancies of the stomach and the colon (Correa, 1988; Heitz and Wegmann, 1980; Pai et al, 1998; Wong et al, 2000) .
Calnexin (Cnx) is characterized as a membranebound nonclassical lectin-like molecule that binds transiently to virtually all newly synthesized glycoproteins (Bergeron et al, 1994; Helenius and Aebi, 2001 ). The luminal domain of Cnx contains a lectin domain, as well as a distinct loop structure that might be involved in direct protein-protein interactions (Chevet et al, 2001) . The Cnx molecule interacts in a unique chaperone system found in the endoplasmic reticulum (ER) of nearly all eukaryotes, the so-called Cnxcalreticulin cycle (Parodi, 2000) . Cnx and other ERassociated molecules allow incorrectly folded proteins to acquire their correct conformation. Foldingcompetent states of the new synthesized proteins are maintained by these molecules (Chevet et al, 2001 ). Therefore, it has been suggested that expression of Cnx is important for secretory activities of cells.
The aim of the study was to investigate whether the expression of Cnx, a protein involved in secretory pathways, might be associated with cellular differentiation and cell-cycle activity of Paneth cells. For this purpose normal mucosa of human small intestine, Paneth cell metaplasia, Paneth cell-rich adenomas, and CaCo2 cells were investigated using a newly generated rat mAb. We hypothesized that expression and distribution of Cnx reflects Paneth cell differentiation and function.
Results

Characterization of the Anti-Cnx mAb
The affinity-purified supernatant of the BB1F10 hybridoma cell line was used in all experiments. First, the mAb was used for immunoscreening experiments (Fig.  1, A and B) . Two specifically recognized plaques were identified and further plaque purified. Full-length sequencing (Cnx CDS 1778 bases) revealed human Cnx in both cases (accession number BC003552). Second, immunoaffinity chromatography was performed, and a single product of approximately 85 kDa was prepared from the elutions by 7.5% SDS-PAGE (Fig. 1C) . The isolated 85-kDa protein was identified as human Cnx (BC003552) by matrix-assisted laser desorption/ionization (MALDI) mass spectrometry (Fig. 1D) . The mAb was subsequently further characterized as IgG2a by isotype-specific mapping (Fig. 1E ).
Figure 1.
Characterization of the anti-calnexin (Cnx) antibody. A and B, Immunoscreening experiments. A, Second step in plaque purification: clones expressing Cnx (black) and clones without any Cnx expression (white) exist together on a filter (ECL staining). B, Last step in plaque purification: one isolated clone expressing Cnx is shown (black; ECL staining). Note, white points in the periphery are used for filter orientation. C, One-dimensional SDS-PAGE of eluted proteins after immunoaffinity chromatography (left). The single reaction product of approximately 85 kDa shows immunoreactivity against Cnx in Western blot analysis (right). D, The 85-kDa protein isolated from the SDS-PAGE gel is identified as human Cnx by matrix-assisted laser desorption/ionization (MALDI)-PSD fragment ion analysis of the parent ion at m/z 1770.60 (arrow; BC003552). E, Isotype-specific mapping reveals that the mAb against Cnx is a rat IgG2a subtype.
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Expression of Cnx in Paneth Cells of Normal Small Intestine
In epithelial cells of normal small intestinal mucosa, a strong signal for Cnx was seen at villi and at the base of crypts (Fig. 2, A and B) . In crypts, these epithelial cells were morphologically identified in serial sections as Paneth cells by their large apical eosinophilic secretory granules. Interestingly, strong immunostaining of the Cnx protein was not found in every Paneth cell (Fig. 2C) . Cnx immunostaining was clearly diminished in Paneth cells containing a large amount of secretory granules. Occasionally, nuclear shrinkage/ karyorrhexis was additionally seen in such cells. Cnx was also found in endocrine cells and in stem cells (Fig. 2D) . Endocrine cells were identified by the basal localization of secretory granules and immunohistochemical staining of chromogranin (data not shown), whereas stem cells were characterized by mitotic figures and nuclear immunostaining of the Ki67 protein. The synthesis of Cnx in normal small intestine and normal gastric mucosa (Fig. 2E ) was corroborated by immunoblots (Fig. 2F) . In normal small intestinal tissues, the distribution of Cnx, Ki67, and the Paneth cell-metabolite lysozyme was further investigated by triple immunofluorescence (Fig. 3, A to F) . Notably, strong immunostaining of lysozyme was found in those Paneth cells that did show a weak immunostaining of the Cnx protein (Fig. 3 , A to C). Nuclear Ki67 protein was never seen in Paneth cells of normal small intestine (Fig. 3, D and E). Cnx was further evaluated by mRNA in situ hybridization experiments. Cnx mRNA were found in Paneth cells and in enterocytes of villi (Fig. 3 , G to I). All appropriate negative controls yielded completely negative results. The data are summarized in Table 1 .
Expression of Cnx in Paneth Cell Metaplasia
In complete intestinal metaplasia, strong immunostaining of the Cnx protein was found in only some Paneth cells (Fig. 4 , A to C). In contrast to the unaffected small intestinal tissue, the diminished Cnx staining did not always correlate with the accumulation of secretory granules. In complete intestinal metaplasia, notably, the Ki67 protein was found in the nuclei of some Paneth cells (Fig. 4D) . Such cells displayed a very low costaining for both Cnx and the Paneth cell marker lysozyme (Fig. 4E) . These immunohistochemical data were corroborated by mRNA in situ hybridization experiments (Fig. 4 , G to I; Table 1 ). In all cases, negative controls yielded completely negative results.
Expression of Cnx in Paneth Cell-Rich Adenomas
In all cases of Paneth cell-rich adenomas investigated (n ϭ 5), detection of Cnx protein, Cnx mRNA, and lysozyme always revealed weak immunostaining when compared with Cnx and lysozyme in normal ileal tissues (Fig. 5, A-I ). Moreover, strong nuclear immunofluorescence of the Ki67 protein was regularly found in these cells (Fig. 5, Table 1) ; negative controls yielded completely negative results.
Expression of Cnx in CaCo2 Cells
To investigate expression and distribution of Cnx during cellular proliferation (mitosis), additional cell culture experiments were performed. As previously described, cellular proliferation/mitosis of CaCo2 cells dramatically increased after treatment with thrombinactivated factor XIII (FXIII) (Cario et al, 1999) . The distribution of the Cnx protein changed in mitosis (Fig.  6, A to F) . In interphase CaCo2 cells, the Cnx protein was distributed in a fine reticulum filling the cytoplasm, concentrated near the nuclear membrane. In prophase and prometaphase, condensation of DNA and establishment of chromosomes were accompanied by condensation of the cytoplasm including the Cnx protein. Immunostaining of the Cnx protein was most prominent in metaphase and early anaphase. In late anaphase and telophase, the distribution of Cnx was increasingly reticular, ultimately concentrated near the newly established nuclear membrane. In every case, the mean area containing the chromosomes was lacking the Cnx protein, whereas small amounts of Cnx were regularly found in the area containing the spindle apparatus. Quantitative analysis of the Cnx protein expression by Western blot technique after 24, 48, and 60 hours of incubation revealed that the total expression of Cnx was unchanged in thrombin-activated FXIII-treated CaCo2 cells (high cellular proliferative activity) when compared with untreated CaCo2 cells (low cellular proliferative activity) (Fig. 7 ).
Discussion
Although a high number of molecules are secreted by Paneth cells (Bry et al, 1994; Ganz, 2000; Nevalainen et al, 1998; Ouellette, 1997 Ouellette, , 1999 Ouellette and Bevins, 2001) , there is no systematic analysis of the secretory/signaling pathways or receptors by which these cells regulate differentiation and function/secretion. Cnx, a multifunctional molecule, is generally involved in secretory pathways and interacts in a unique chaperone system (Bergeron et al, 1994; Helenius and Aebi, 2001; Parodi, 2000) . In this study, the expression and synthesis of Cnx in Paneth cells was investigated.
In normal small intestine, Cnx was strongly expressed and synthesized by Paneth cells without storage of secretory granules in their cytoplasm. Immunostaining of the Cnx protein was diminished with advanced stage of cell life, indicated by an increased density of secretory granules (immunostaining of lysozyme). Moreover, the immunostaining of Cnx was further decreased in the case of nuclear shrinkage/ karyorrhexis (late stage of cell life). The lack of nuclear expression of Ki67 protein in normal Paneth cells is confirmed by previously recorded data, which show that these cells are postmitotic and derive from a multipotent stem cell located near the base of crypts of Lieberkühn (Bry et al, 1994) . With regard to Paneth cell morphology and synthesis/storage of secretory granules (lysozyme), the characteristic Cnx immunostaining reflects different stages of Paneth cell differentiation and function. However, the variation in Cnx and lysozyme immunostaining and the differences in cellular morphology indicate that Paneth cells of different cellular activity/life stage exist together in a single crypt of the normal human small intestine.
Concerning intestinal metaplasia, histopathologic and histochemical techniques allow the identification of different types: (i) type I, which is characterized by the presence of Paneth cells, absorptive cells, and goblet cells secreting sialomucins and which corresponds to the small intestine phenotype (complete intestinal metaplasia); (ii) type II, which is characterized by the presence of columnar and goblet cells secreting sialomucins; and (iii) type III, which is characterized by the presence of columnar and goblet cells secreting sulfomucins (Rouzier and Robine, 2001) . Paneth cells are not found in type II and type III intestinal metaplasia; therefore the lesions have been designated as incomplete intestinal metaplasia. It has been suggested that intestinal metaplasia might be a preneoplastic hyperproliferative lesion of the stomach (Cahill et al, 1996; Correa, 1988; De Bolos et al, 2001; Dixon, 2001; Endoh et al, 1999; Morson, 1955; Rokkas et al, 1991; Rouzier and Robine, 2001; Wong et al, 2000; Tahara, 1995) . However, cellular differentiation and proliferative status of Paneth cells in complete intestinal metaplasia (type I metaplasia) of the stomach has not been extensively examined. Our findings that the expression of Cnx by Paneth cells is reduced in complete intestinal metaplasia of the stomach and that nuclear expression of the Ki67 protein is found in such Paneth cells argue for a dysregulated cell cycle of Paneth cells in complete intestinal metaplasia. These results are in agreement with data recorded by Wong et al (2000) . However, further studies are necessary to elucidate whether complete intestinal metaplasia constitutes a precancerous lesion in itself or provides a milieu conductive to the development of gastric cancer.
In Paneth cell-rich adenomas, Cnx was significantly reduced and accompanied by an even higher proliferative activity (Ki67 expression) when compared with complete intestinal metaplasia. These findings indicate a misdirected cellular differentiation of Paneth cells, which seems to be more prominent in Paneth cell-rich adenomas than in complete intestinal metaplasia. Although both conditions are considered as preneoplastic hyperproliferative lesions, it is surprising that tumors derived from Paneth cells are not frequent and that the entity of Paneth cell-carcinoma has not been established yet (Endoh et al, 1999; Heitz and Wegmann, 1980; Nevalainen et al, 1998; Rubio et al, 1996) . However, it should be taken into consideration that Paneth cell-rich carcinomas might derive from dysregulated stem cells rather than from formerly well-differentiated Paneth cells.
Expression and distribution of the Cnx protein in mitosis were further investigated by cell culture experiments. Because primary cultures of differentiated human Paneth cells are not yet well established, the intestinal epithelial cell line CaCo2 was used (Cario et al, 1999; Jumarie and Malo, 1991) . In mitotic CaCo2 cells, immunoreactivity to Cnx was found in numerous dispersed cisternae and vesicles, a common phenomenon observed for proteins associated with the ER (Jesch and Linstedt, 1998). The strong immunostaining for Cnx in such metaphase cells is obviously a result of a condensation of the cytoplasm, including the ER vesicles. Western blot analyses gave evidence that the total amount of immunoreactive Cnx was not affected by mitosis itself. Although the mechanisms which drive the mitotic cisternal tubulation and condensation are currently unknown, some authors have proposed that these effects result from an imbalance in membrane traffic on the secretory pathway of mitotic cells (Farmaki et al, 1999) .
In this study, the distribution of Cnx protein was generally corroborated by the results of mRNA in situ 
Materials and Methods
Patients
A total of 15 small intestinal samples (6 men, 9 women; mean age, 51 years; range, 32 to 62 years), 35 gastric 
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samples with complete intestinal metaplasia (11 men, 24 women; mean age, 63 years; range, 48 to 83 years), and 5 cases of Paneth cell-rich adenoma of the colon/rectum (3 men, 2 women; mean age, 65 years; range, 51 to 75 years) were included in the study. All tissues were obtained by biopsy. For molecular procedures, normal gastric and small intestinal tissues were used from surgical resections for gastric cancer or cancer of the ascending colon (1 men, 4 women; mean age, 61 years; range, 33 to 80 years). Mucosal tissue layers were mechanically dissected from the underlying submucosa, immediately cooled in liquid nitrogen, and stored at Ϫ80°C until use. All diagnoses were established independently by conventional histologic criteria on hematoxylin and eosin-stained sections of paraffin-embedded tissues by two authors (FA and NG). The use of human tissues was approved by Heidelberg University.
Production of mAb
Antibody was obtained by fusing immune B cells from the spleen of a boost primed Sprague-Dawley rat (Janvier, Le Geneste-St Isle, France) with P3X63Ag8 (Yokoyama, 1991) . Briefly, immunization of the 8-week-old rat was performed using a liquid preparation of mature Cnx protein in 0.9% NaCl from normal purified human small intestinal crypts (Grossmann et al, 1998) of a 55-year-old female. First and second immunizations were performed subcutaneously in the presence of Specol adjuvants (ID-DLO, Lelystad, Netherlands). The antigen was additionally applied in five booster immunizations intravenously, without Specol, over 70 days. Fusion of harvested spleen cells and tumor (myeloma) cells (ratio 5:1) was performed at 37°C with application of polyethylene glycol (Sigma, Deisenhofen, Germany). The resulting pellet was harvested and plated into tissue culture plates (Greiner, Frickenhausen, Germany) with RPMI 1640 (Gibco Invitrogen Corporation, New York)/15% FCS (Sigma)/HAT (hypoxanthine, azaserine, and thymidine) medium. On day 15, HAT was replaced by HT (both substances purchased from Sigma), and the RPMI 1640/15% FCS/HT medium was used for a further 5 days before a standard RPMI 1640/10% FCS medium was applied for screening experiments. The supernatants were tested in a first screening assay for the presence of the desired antibody with a reticular cytoplasmic staining: cryosections of human intestine were incubated with undiluted supernatants for 1 hour and then visualized by a Cy-2-labeled anti-rat IgG antibody (Rockland, Gilbertsville, Pennsylvania). Candidate hybridomas identified were subcloned and subsequently tested. The hybridoma cell line BB1F10 was established, when stable clones were identified, frozen in liquid nitrogen, and successfully thawed. The mAb was purified by antibody affinity chromatography using a HiTrap Protein G HP column following the manufacturer's instructions (Amersham Pharmacia Biotech, Little Chalfont, England) and further characterized by isotype-specific mapping using a Western blot technique (see below).
cDNA Library and Immunoscreening
A sample of purified 2-g mRNA from human intestinal mucosa was used for cDNA synthesis and construction of a custom library in TriplEx (Promega, Madison, Wisconsin). Approximately 2.4 ϫ 10 6 plaques were plated, transferred to nitrocellulose filters (Schleicher & Schuell, Dassel, Germany) treated with isopropylthiogalactoside (Sigma), and subsequently incubated with the purified mAb overnight (dilution 1:2500 in 5% skim milk TBST). For further detection a secondary horseradish peroxidase (HRP)-labeled antibody against rat IgG (1:5,000; Santa Cruz Biotechnology, Santa Cruz, California) and the ECL substrate (Amersham Pharmacia Biotech) were used.
Analysis of Inserts
Conversion of TriplEx in pTriplEx was performed following the manufacturer's protocol (Clontech, Palo Alto, California). The inserts were PCR amplified (4 minutes of denaturation at 94°C, 30 cycles of denaturation at 94°C for 60 seconds, annealing at 55°C for 60 seconds, and extension at 72°C for 60 seconds) using a set of TriplEx screening amplimers (Clontech). PCR products were sequenced by an automated sequencing system (ABI, Weiterstadt, Germany). All sequencing reactions were performed with 100 ng of each purified PCR product and 10 pmol of the appropriate primer (see above) using the Big Dye Terminator kit (ABI). Reactions were run on an ABI 3700 capillary sequencer according to the manufacturer's recommendations. Sequences were assembled using the program SeqMan (Lasergene, Madison, Wisconsin), and GenBank searches were performed.
Protein G Bead-mAb Column and Immunoaffinity Chromatography
The affinity-purified mAb (approximately 13 mg/ml) was covalently bound to protein G Sepharose (Amersham Pharmacia Biotech) using dimethylpimelimidate-dihydrochloride (Sigma). The matrix was disposed in a 5-ml column (Pierce, Rockford, Illinois). Immunoaffinity chromatography was performed according to the manufacturer's recommendations. Briefly, total protein was isolated from human normal intestine as previously described (Gassler et al, 2001) . After an incubation period of 24 hours, the protein lysate was removed and the column was washed twice in PBS. Elution of the antigen was achieved by application of 1 ml of 0.1 M glycine, pH 2.6. The samples were purified by SDS-PAGE (7.5%) and fur- 
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ther analyzed by Western blot technique and MALDI mass spectrometry (for details see below).
MALDI Mass Spectrometry
The protein band (85 kDa) was excised from the 7.5% gel (see below). The gel pieces were washed repeatedly and tryptic digestion was performed at 37°C overnight using sequencing grade modified trypsin (Promega) in 40 mM ammonium bicarbonate. The reaction was stopped by freezing. MALDI mass spectra were recorded in the positive ion reflector mode with delayed extraction on a Reflex II time-of-flight instrument (Bruker-Daltonik GmbH, Bremen, Germany) equipped with a SCOUT multiprobe inlet and a 337-nm nitrogen laser. Ion acceleration voltage was set to 20.0 kV, the reflector voltage was set to 21.5 kV, and the first extraction plate was set to 15.4 kV. Mass spectra were obtained by averaging 50 to 200 individual laser shots. Calibration of the spectra was performed internally by a two-point linear fit using the autolysis products of trypsin at m/z 842.50 and m/z 2211.10.
Sample preparation for post-source decay (PSD) analysis was achieved by cocrystallization of matrix (alpha-cyano-4-hydroxycinnamic acid saturated in 50% acetonitrile/water) with ZipTip C18 (Millipore, Bedford, Massachusetts) concentrated samples as previously described (Regula et al, 2000) . PSD analysis was performed in the positive ion reflector mode with delayed extraction by setting an ion gate width of 40 Da around the ion of interest. Data were acquired in 14 segments by decreasing the reflector voltage in a stepwise fashion. For each segment 100 to 200 individual laser shots were accumulated. The fragment ion spectrum was obtained by pasting together all segments to a single spectrum using the FAST software provided by Bruker-Daltonik. Fragment ion calibration was performed externally with the fragment masses of the adrenocorticotropic hormone 18-39 clip.
Singly charged monoisotopic peptide masses were used as inputs for database searching. Searches were performed against the NCBInr database using the ProFound search algorithm (http://129.85.19.192/ prowl-cgi/ProFound.exe) and the protein prospector software developed at the University of California, San Francisco (http://prospector.ucsf.edu). Mass tolerance for the monoisotopic peptide masses was set to Ϯ100 ppm or Ϯ0.1 Da. Searches with fragment masses from PSD experiments were performed against the NCBInr database using the MS-Tag search algorithm provided by the protein prospector software package. Parent mass tolerance was set to Ϯ0.1 Da, and fragment ion tolerance was set to Ϯ0.7 Da.
Cell Culture
CaCo2 cells (HTB-37; ATCC) were routinely cultured in DMEM (Gibco Invitrogen) containing 10% FCS (Sigma). All experiments were performed with cells between passages 50 and 65. Recombinant human FXIII, consisting of two ␣-chains (␣ 2 configuration), and thrombin (1,000 IU/ml) were kindly provided by the Centeon GmbH (Marburg, Germany).
Cell Proliferation Assay
The assay was performed following the protocol of Cario et al (1999 4 cells per group were homogenized in 3 ml of TriReagent (Sigma) on ice using the Ultra Turrax equipment (IKA Labortechnik, Staufen, Germany).
SDS-PAGE and Western Blot Analysis
Proteins resolved by one-dimensional SDS-PAGE (7.5%; approximately 15 g of total protein loaded per lane) were transferred to an Immobilon-P (Millipore) polyvinylidene difluoride membrane using a semi-dry blot system. Molecular weight markers were purchased from Amersham Pharmacia Biotech. For immunoreaction, the anti-Cnx mAb (1:1,000), the secondary HRP-conjugated anti-rat antibody [1:10,000; Santa Cruz), and the ECL substrate (Amersham Pharmacia Biotech) were applied as previously described (Gassler et al, 2001 ). For isotype-specific mapping, the following secondary antibodies were used: mouse anti-rat IgG1, mouse anti-rat IgG2a, and mouse antirat IgG2b (all antibodies from Serotec, Oxford, United Kingdom). The amount of each sample analyzed was additionally adjusted to the intensity of ␤-actin staining. Therefore, blots were stripped of antibodies and reprobed with an anti-␤-actin antibody (0.4 g/ml; Sigma) and a secondary HRP-conjugated anti-mouse antibody (1:10,000; Santa Cruz). For antibody stripping, blots were immersed in pure methanol, washed in water, and incubated in stripping buffer consisting of 2% SDS, 100 mM ␤-mercaptoethanol, and 62.5 mM Tris-HCl (pH 7.5) for 30 minutes at 50°C. Subsequently, blots were processed as described. Negative controls included similarly processed blots in which the primary antibody was totally omitted.
Immunohistochemistry/Immunofluorescence/Data Analysis
Paraffin-embedded tissues were sectioned (2 m), mounted on pretreated slides (DAKO, Glostrup, Denmark), air dried overnight, and subsequently deparaffinized. After microwave treatment (citrate buffer; 500 W, 10 minutes), the anti-Cnx antibody ( was applied and tissues were incubated for 1 hour at room temperature in a moist chamber. In additional experiments on serial sections, a mouse antichromogranin mAb (1:10; Linaris, WertheimBettingen, Germany) was applied. Antibody labeling was visualized using the routine ABC technique and diaminobenzidine as a chromogen following the manufacturer's recommendations (DAKO).
For triple-labeling experiments, sections were incubated for 60 minutes with a mixture of all primary antibodies (rat anti-Cnx [10 g/ml]; rabbit anti-lysozyme/muramidase [50 g/ml; DAKO]; mouse antiKi67/Mib-1 [70 g/ml; Dianova, Hamburg, Germany]) and afterward detected with the appropriate secondary antibodies (Cy2 anti-rat [1:200; Rockland]; AMCA anti-rabbit [1:20; Dianova]; tetramethylrhodamine isothiocyanate anti-mouse [1:30; Dianova]). Each incubation time was followed by three 3-minute washes with PBS. Histosafe-mounted sections were viewed with an ultraviolet laser scanning microscope (LSM 510; Zeiss, Jena, Germany). For simultaneous immunofluorescence, different laser systems were used (346, 488, and 543 nm) with the corresponding barrier filters. Nuclear staining of cultured CaCo2 cells was performed with Hoechst 33258 (Sigma). Computer images were collected on optical memory discs and arranged with the Corel Draw program. For single immunofluorescence the staining procedure was identical to that detailed above. Negative controls included similarly processed sections in which the primary antibody had been totally omitted or replaced by the appropriate immunoglobulin fraction.
To estimate the number of Paneth cells with different immunophenotypes (triple immunostaining against Cnx, lysozyme, Ki67), five randomly selected microscopic fields were analyzed blindly (BH) per tissue section (one section per patient; see above). The number of Paneth cells was counted manually under fluorescence microscope (Axiophot 2; Zeiss) using a ϫ40 objective; data are expressed in percent values.
mRNA In Situ Hybridization
For mRNA in situ hybridization experiments, the Cnx insert of pTriplEx (see above) was directionally cloned into the EcoRI-SalI side of pBluescript II KS (Ϯ) phagemid (Stratagene, La Jolla, California). To generate antisense and sense RNA probes for in situ hybridization experiments, the plasmid was restricted with EcoRI or SalI and then transcribed with T3 or T7 RNA polymerase (Roche, Mannheim, Germany), respectively. The in vitro transcription procedure was performed according to the protocol supplied by the manufacturer (Roche). Deparaffinized tissue sections were postfixed in 4% paraformaldehyde/PBS for 10 minutes and treated with proteinase K (8 g/ml in PBS) (Roche) for 30 minutes at 37°C. To reduce background, slides were washed in PBS and acetylated for 15 minutes in 0.1. M triethanolamine, pH 8.0, containing 0.25% acetic anhydride. To improve the penetration of the probes during the in situ hybridization experiments, the transcripts were shortened to a calculated average length of 250 bases by alkaline hydrolysis. Hybridization with a probe concentration of 2 to 4 nanogram probe per microliter of hybridization mixture was performed overnight at a temperature of 46°C. To demonstrate the specificity of the probe, control experiments were performed with sense probes on alternate tissue sections. Negative controls included tissue sections in which the antisense/sense probe or the anti-digoxigenin antibody was replaced by PBS.
